Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/ADM.0000000000000755 http://scihub22266oqcxt.onion/10.1097/ADM.0000000000000755 33156267!7892198!33156267     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Addict+Med 2020 ; 14 (6): e293-e296 Nephropedia Template TP {{tp|p=33156267|t=2020. Treatment for Anxiety and Substance Use Disorders During the COVID-19 Pandemic: Challenges and Strategies |pdf=|usr=}}{{33156267}} gab.com Text Treatment for Anxiety and Substance Use Disorders During the COVID-19 Pandemic: Challenges and Strategies JO: J Addict Med http://www.kidney.de/pget.php?&tw=1&pmid=33156267 #FOAvip : The COVID-19 pandemic is likely to exacerbate existing anxiety and substance use disorders (SUDs) and increase vulnerability among individuals previously free of these conditions. Numerous pandemic-related stressors-coronavirus infection fears, social distancing and isolation, activity restrictions, financial insecurity and unemployment, caregiving or childcare responsibilities-place a substantial burden both on the general population and on many health care providers. Anxiety symptoms such as worry, tension, irritability, difficulty concentrating, and sleep disruption are increasingly prevalent. For individuals in SUD treatment, anxiety can complicate efforts to achieve treatment goals. In this commentary, we outline the potential impact of anxiety on substance use problems during the COVID-19 crisis and describe key behavioral, pharmacological, and digital health treatment considerations. We highlight populations of special concern due to heightened vulnerability and challenges accessing services, strategies to support health care providers, and directions for future research. Twit Text FOAVip Treatment for Anxiety and Substance Use Disorders During the COVID-19 Pandemic: Challenges and Strategies ????J Addict Med http://www.kidney.de/pget.php?&tw=1&pmid=33156267 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33156267 #FOAvip English Wikipedia <ref>{{Cite pmid|33156267}}</ref> Treatment for Anxiety and Substance Use Disorders During the COVID-19 Pandemic: Challenges and Strategies #MMPMID33156267 Satre DD; Iturralde E; Ghadiali M; Young-Wolff KC; Campbell CI; Leibowitz AS; Sterling SA J Addict Med 2020[Dec]; 14 (6): e293-e296 PMID33156267show ga : The COVID-19 pandemic is likely to exacerbate existing anxiety and substance use disorders (SUDs) and increase vulnerability among individuals previously free of these conditions. Numerous pandemic-related stressors-coronavirus infection fears, social distancing and isolation, activity restrictions, financial insecurity and unemployment, caregiving or childcare responsibilities-place a substantial burden both on the general population and on many health care providers. Anxiety symptoms such as worry, tension, irritability, difficulty concentrating, and sleep disruption are increasingly prevalent. For individuals in SUD treatment, anxiety can complicate efforts to achieve treatment goals. In this commentary, we outline the potential impact of anxiety on substance use problems during the COVID-19 crisis and describe key behavioral, pharmacological, and digital health treatment considerations. We highlight populations of special concern due to heightened vulnerability and challenges accessing services, strategies to support health care providers, and directions for future research. |Anxiety Disorders/etiology/*therapy[MESH] |COVID-19[MESH] |Coronavirus Infections/*epidemiology/prevention & control/psychology[MESH] |Health Services Accessibility[MESH] |Humans[MESH] |Infection Control[MESH] |Pandemics/prevention & control[MESH] |Pneumonia, Viral/*epidemiology/prevention & control/psychology[MESH] |Substance-Related Disorders/etiology/*therapy[MESH]Treatment for Anxiety and Substance Use Disorders During the COVID-19 (epmc).pdf DeepDyve Pubget Overpricing